Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapy
Chelsea C Pinnix, Andrew Wirth, Sarah A Milgrom, Therese Y Andraos, Michalis Aristophanous, Mary Pham, Donald Hancock, Ethan B Ludmir, Jillian R Gunther, Michelle A Fanale, Yasuhiro Oki, Loretta Nastoupil, Hubert H Chuang, N George Mikhaeel, Bouthaina S Dabaja
Leukemia & Lymphoma | TAYLOR & FRANCIS LTD | Published : 2018
Cardiophrenic lymph nodes (CPLNs) are occasionally involved in Hodgkin lymphoma (HL). We characterized the incidence of CPLN involvement among 169 HL patients and evaluated outcomes after treatment with omission of the CPLN region from the involved-site radiation therapy (ISRT) field. Three types of RT fields were used: standard (S)-ISRT, reduced-dose (RD)-ISRT (lower dose to CPLNs, standard to other sites), or modified (M)-ISRT (omission of CPLNs). CPLNs were involved at diagnosis in 29 patients (17%). Of the 20 patients who received RT after complete response to chemotherapy, 4(20%) received S-ISRT, 8(40%) RD-ISRT, and 8(40%) M-ISRT. The four-year progression-free survival was 94.7%. One r..View full abstract
Awarded by National Cancer Institute, National Institutes of Health
Awarded by NATIONAL CANCER INSTITUTE
This study was supported in part by Cancer Center Support (Core) [Grant CA016672] from the National Cancer Institute, National Institutes of Health, and The University of Texas MD Anderson Cancer Center.